Mpox: How Are 47 Countries Coping with 3,924 Cases and 30 Deaths in July?
Click to start listening
Synopsis
The ongoing threat of mpox is highlighted in a recent WHO report, revealing that 47 countries reported 3,924 cases and 30 deaths in July. This alarming trend raises questions about global health preparedness and response strategies. Discover the latest insights into the mpox outbreak and its implications for public health worldwide.
Key Takeaways
- 47 countries reported 3,924 confirmed mpox cases in July.
- 30 deaths were associated with the outbreak.
- First cases of mpox reported in Senegal and Türkiye.
- Community transmission continues in Kenya.
- Overall cases are declining in the Democratic Republic of Congo.
New Delhi, Aug 29 (NationPress) Mpox remains a significant global health threat, with 47 nations documenting a cumulative total of 3,924 confirmed cases, including 30 fatalities during July, as reported by the World Health Organization (WHO) on Friday.
The report detailing the multi-country outbreak of mpox in July indicates that various clades of the monkeypox virus (MPXV) are still prevalent in numerous countries.
"If mpox outbreaks are not swiftly contained and human-to-human transmission is not disrupted, they will continue to represent a risk of ongoing community transmission," the report highlighted.
In July, Senegal confirmed its first mpox cases. Efforts are being made to identify the specific clade. Türkiye also reported its first instances of mpox tied to clade Ib MPXV, while the Democratic Republic of Congo has documented its initial cases associated with clade IIb MPXV.
Moreover, while the South-East Asian and Western Pacific regions noted an uptick in cases in July, the African Region, European Region, and the Region of the Americas experienced a decrease. The Eastern Mediterranean Region reported no mpox cases during July, according to the WHO.
"In the past six weeks, twenty-one African countries have reported continuous mpox transmission. Clade IIb MPXV remains prevalent in West Africa, while Central African nations report both clade Ia and Ib MPXV, and East African countries report clade Ib MPXV," the report mentioned.
Importantly, the recent overall decline in confirmed cases across the continent is primarily due to a reduction in cases from the Democratic Republic of Congo, Sierra Leone, and Uganda.
Kenya continues to see community transmission and has been experiencing a gradual rise in confirmed cases reported throughout 2025. Most cases are reported among young adults, with all but one death occurring among individuals living with HIV.
Meanwhile, nations like China, Germany, Türkiye, and the United Kingdom have reported additional mpox cases linked to clade Ib MPXV since June. These instances have been associated with travel, and community transmission of clade Ib MPXV continues to be observed only in countries located in central and eastern Africa, according to the WHO report.
Point of View
It's crucial to approach the mpox outbreak with a focus on factual reporting and public health awareness. The WHO’s findings emphasize the importance of rapid response and community engagement to curb the spread of mpox. Our commitment to transparency ensures that the public remains informed and prepared for potential health risks.
NationPress
30/08/2025
Frequently Asked Questions
What is mpox?
Mpox, also known as monkeypox, is a viral disease caused by the monkeypox virus, which can lead to symptoms like fever, rash, and swollen lymph nodes.
How is mpox transmitted?
Mpox can be transmitted through direct contact with an infected person, animal, or contaminated materials, as well as through respiratory droplets.
What regions are most affected by mpox?
Currently, the African Region, South-East Asia, and parts of Europe and the Americas are reporting cases of mpox.
What measures are being taken to control mpox outbreaks?
Countries are implementing public health measures such as contact tracing, vaccination, and health education to control mpox outbreaks.
Is there a vaccine for mpox?
Yes, vaccines that are effective against smallpox, such as JYNNEOS, are also believed to offer protection against mpox.
